| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Edgewise Therapeutics, Inc. (EWTX) have been net sellers, shedding 43,429 shares worth roughly $1.9M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 52.5K | $1.98M | - | |
| Other | 31.8K | $1.20M | - | |
| Other | 31.5K | $1.19M | - | |
| Dir | 25.1K | $947.3K | - | |
| Dir | 19.8K | $746.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | Kevin Koch51 | President and CEO | Sale+OE10b5-1 | 9,536 | $30.13 | $287,315.62 | -39.7% | -49.4% | +1.4% | |
| Feb 6, 2025 | Alan J Russell74 | Chief Scientific Officer | Sale+OE10b5-1 | 9,215 | $30.04 | $276,776.12 | -38.3% | -49.4% | +1.4% | |
| Feb 5, 2025 | Behrad Derakhshan50 | Chief Business Officer | Sale+OE | 10,000 | $30.03 | $300,300.00 | -37.3% | -52.1% | -9.5% | |
| Jan 28, 2025 | Joanne M. Donovan49 | CMO | Sale+OE10b5-1 | 25,000 | $27.63 | $690,657.50 | -60.4% | -43.6% | +3.2% | |
| Dec 30, 2024 | Alan J Russell74 | Chief Scientific Officer | Sale+OE10b5-1 | 100,000 | $27.37 | $2,737,470.00 | -87.1% | -18.7% | -9.3% | |
| Dec 24, 2024 | Marc Semigran | Chief Development Officer | Sale+OE10b5-1 | 29,709 | $29.69 | $881,915.22 | -81.6% | -21.1% | -7.9% | |
| Sep 23, 2024 | John R Moore | General Counsel | Sale+OE | 70,922 | $28.15 | $1,996,574.40 | -95.6% | +13.2% | -43.0% | |
| Sep 20, 2024 | Alan J Russell74 | Chief Scientific Officer | Sale+OE | 75,000 | $28.27 | $2,120,101.20 | -85.5% | +8.9% | -49.6% | |
| Sep 20, 2024 | Joanne M. Donovan49 | CMO | Sell | 7,162 | $28.29 | $202,602.95 | -33.0% | +8.9% | -49.6% | |
| Sep 20, 2024 | Behrad Derakhshan50 | Chief Business Officer | Sale+OE | 42,068 | $29.03 | $1,221,133.08 | -73.6% | +8.9% | -49.6% |